NCT03865043View on ClinicalTrials.gov

Vascular Complications and Bleeding After Transfemoral TAVI

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Severe and Symptomatic Aortic StenosisUndergoing TAVI
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03865043 - Vascular Complications and Bleeding After Transfemoral TAVI | Biotech Hunter | Biotech Hunter